Trade

with

Merck & Co Inc
(NYSE: MRK)
US Markets Closed
AdChoices
54.05
+0.03
+0.06%
After Hours :
54.06
+0.01
+0.02%

Open

54.22

Previous Close

54.02

Volume (Avg)

12.06M (9.14M)

Day's Range

53.92-54.27

52Wk Range

44.62-61.33

Market Cap.

155.83B

Dividend Rate (Yield )

1.76 (3.26%)

Beta

0.43

Shares Outstanding

2.88B

P/E Ratio (EPS)

28.49 (1.90)

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
  • Management effectiveness
Industry Drug Manufacturers – Major
Highlights
Analyst Recommendation: Outperform
    • Revenue

    • 44.03B

    • Net Income

    • 4.40B

    • Market Cap.

    • 155.83B

    • Enterprise Value

    • 165.50B

    • Net Profit Margin %

    • 12.89

    • PEG (Price/Earnings Growth) Ratio

    • 4.51

    • Beta

    • 0.43

    • Forward P/E

    • 15.06

    • Price/Sales

    • 3.67

    • Price/Book Value

    • 3.22

    • Price/Cash flow

    • 14.90

      • EBITDA

      • 13.33B

      • Return on Capital %

      • 5.48

      • Return on Equity %

      • 11.71

      • Return on Assets %

      • 5.48

      • Book Value/Share

      • 16.76

      • Shares Outstanding

      • 2.88B

      • Last Split Factor (Date)

      • 2:1 (2/17/1999)

      • Last Dividend (Ex-Date)

      • 0.44 (9/11/2014)

      • Dividend Declaration Date

      • 7/23/2014

      Analyst Recommendation
      10/17/2014
      Outperform
        • 1 Year Price Target

        • 64.00

        • Credit Rating

        • AA

        • Analysts

        • 5

        • EPS Estimate

        • 2.97

        • Cashflow Estimate

        • 4.84

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • -0.70

          • 0.89

          • Net Income

            YTD/YTD (last year)

          • -28.60

          • 7.80

          • Net Income

            Q/Q (last year)

          • 121.20

          • 4.50

          • Sales (Revenue)

            5-Year Annual Average

          • 13.05

          • 6.10

          • Net Income

            5-Year Annual Average

          • -10.80

          • 3.73

          • Dividends

            5-Year Annual Average

          • 2.62

          • 2.17

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 59.80

            • 69.92

            • Pre-Tax Margin

            • 15.46

            • 21.84

            • Net Profit Margin

            • 12.89

            • 18.37

            • Average Gross Margin

              5-Year Annual Average

            • 63.70

            • 71.90

            • Average Pre-Tax Margin

              5-Year Annual Average

            • 21.10

            • 21.92

            • Average Net Profit Margin

              5-Year Annual Average

            • 17.00

            • 903.40B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • 0.38

              • 0.32

              • Current Ratio

              • 1.87

              • 1.92

              • Quick Ratio

              • 1.14

              • 1.31

              • Interest Coverage

              • 9.50

              • 17.64

              • Leverage Ratio

              • 2.02

              • 2.03

              • Book Value/Share

              • 16.76

              • 14.72

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • 30.96

                • 21.41

                • P/E Ratio 5-Year High

                • 32.33

                • 193.96

                • P/E Ratio 5-Year Low

                • 15.54

                • 87.26

                • Price/Sales Ratio

                • 3.99

                • 3.63

                • Price/Book Value

                • 3.50

                • 3.62

                • Price/Cash Flow Ratio

                • 14.90

                • 13.57

                • Key Metrics

                • Company

                  • Shares Short

                    as of 9/30/2014

                  • 23.07M

                  • Short Ratio

                    as of 9/30/2014

                  • 2.52

                  • Short % of Float

                    as of 9/30/2014

                  • 0.79

                  • Shares Short

                    prior month

                  • 24.45M

                  • Trailing Annual Dividend Yield

                  • -

                  • 5 Year Average Dividend Yield

                  • 0.04

                  • Key Metrics

                  • Company

                    • Payout Ratio

                    • 92.25

                    • Dividend Date

                    • 7/23/2014

                    • Ex-Dividend Date

                    • 9/11/2014

                    • Last Split Factor

                      new per old

                    • 2:1

                    • Last Split Date

                    • 2/17/1999

                    • Key Metrics

                    • Company

                    • Industry

                      • Return on Equity %

                        (5-Year Average)

                      • 11.71

                        (13.20)

                      • 17.42

                        (18.66)

                      • Return on Assets %

                        (5-Year Average)

                      • 5.48

                        (6.60)

                      • 8.45

                        (8.77)

                      • Return on Capital %

                        (5-Year Average)

                      • 8.55

                        (10.70)

                      • 12.41

                        (13.18)

                      • Income/Employee

                      • 73.87k

                      • 90.07k

                      • Inventory Turnover

                      • 2.71

                      • 2.46

                      • Asset Turnover

                      • 0.43

                      • 0.46

                      Current Historical
                      Financials
                      • Income Statement
                      • Balance Sheet
                      • Cash Flow
                      Operating Income
                      6.36B
                      Operating Margin
                      14.44
                      Total Equity
                      -
                      Retained Earnings
                      -
                      Free Cashflow
                      -
                      Price/Cashflow
                      14.90
                      Ownership

                      Institutional Ownership

                      76.91%

                      Top 10 Institutions

                      30.43%

                      Mutual Fund Ownership

                      42.75%

                      Float

                      99.97%

                      5% / Insider Ownership

                      0.07%

                      Corporate insiders or major stockholders reporting trading activity in the stock.

                      Top Mutual Fund Owners

                      Top Institutional Owners

                      Mutual Fund Name

                      Institution Name

                      • Mutual Fund Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • VA CollegeAmerica Income Fund of America

                      •  

                        50,113,640

                      • 0.85

                      • 1.74

                      • VA CollegeAmerica Washington Mutual

                      •  

                        48,141,400

                      • 2.98

                      • 1.67

                      • Vanguard Total Stock Mkt Idx

                      •  

                        47,470,515

                      • 0.02

                      • 1.65

                      • Vanguard Health Care Fund

                      •  

                        33,889,948

                      • -4.85

                      • 1.17

                      • Vanguard Five Hundred Index Fund

                      •  

                        29,947,408

                      • -1.06

                      • 1.04

                      • Vanguard Institutional Index Fund

                      •  

                        29,224,632

                      • -2.33

                      • 1.01

                      • SPDR® S&P 500 ETF

                      •  

                        28,748,295

                      • -1.09

                      • 0.91

                      • Vanguard Wellington™

                      •  

                        27,713,952

                      • 0.00

                      • 0.96

                      • VA CollegeAmerica American Balanced

                      •  

                        25,315,000

                      • -1.61

                      • 0.88

                      • Franklin Income Fund

                      •  

                        25,000,000

                      • 0.00

                      • 0.86

                      • Institution Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • Capital World Investors

                      •  

                        174,926,284

                      • +0.82%

                      • 6.03

                      • Wellington Management Company, LLP

                      •  

                        152,491,759

                      • -2.92%

                      • 5.26

                      • Vanguard Group, Inc.

                      •  

                        150,630,864

                      • +1.79%

                      • 5.19

                      • State Street Corp

                      •  

                        124,323,638

                      • -3.17%

                      • 4.29

                      • BlackRock Fund Advisors

                      •  

                        89,275,723

                      • -2.17%

                      • 3.08

                      • T. Rowe Price Associates, Inc.

                      •  

                        45,526,605

                      • +0.81%

                      • 1.57

                      • Northern Trust Investments, N.A.

                      •  

                        43,810,714

                      • +0.19%

                      • 1.51

                      • Fidelity Management and Research Company

                      •  

                        42,815,731

                      • -20.28%

                      • 1.48

                      • Dodge & Cox

                      •  

                        35,960,137

                      • -10.01%

                      • 1.24

                      • Government Pension Fund of Norway - Global

                      •  

                        34,730,520

                      • -27.06%

                      • 0.78

                      Company Profile

                      Sector

                      Healthcare

                      Industry

                      Drug Manufacturers – Major

                      Type

                      Slow Growth

                      Style

                      Large Value

                      Merck & Co Inc was incorporated in New Jersey in 1970. The Company is a health care company that delivers health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products, w...morehich it markets directly and through its joint ventures. The Company’s operations are mainly managed on a products basis and are comprised of four operating segments, which are the Pharmaceutical, Animal Health, Consumer Care and Alliances segments, and one reportable segment, which is the Pharmaceutical segment. The Pharmaceutical segment includes human health pharmaceutical and vaccine products marketed either directly by the Company or through joint ventures. Human health pharmaceutical products consist of therapeutic and preventive agents, generally sold by prescript...moreion, for the treatment of human disorders. The Company sells these human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies and managed health care providers such as health maintenance organizations, pharmacy benefit managers and other institutions. Vaccine products consist of preventive pediatric, adolescent and adult vaccines, primarily administered at physician offices. The Company sells these human health vaccines primarily to physicians, wholesalers, physician distributors and government entities. The Company also has animal health operations that discover, develop, manufacture and market animal health products, including vaccines, which the Company sells to veterinarians, distributors and animal producers. Additionally, the Company has consumer care operations that develop, manufacture and market over-the-counter, foot care and sun care products, which are sold through wholesale and retail drug, food chain and mass merchandiser outlets, as well as club stores and specialty channels. The Company’s competitors include other worldwide research-based pharmaceutical companies, smaller research companies with more limited therapeutic focus, and generic drug and consumer health care manufacturers. The Company’s activities, including research, preclinical testing, clinical trials and manufacturing and marketing its products, are subject to regulation by numerous federal, state and local governmental authorities in the United States, including the FDA, and by foreign regulatory authorities, including the European Commission.lessless

                      Key People

                      Kenneth C. Frazier

                      CEO/Chairman of the Board/Director/President

                      Robert M. Davis

                      Executive VP/CFO

                      Clark Golestani

                      Chief Information Officer/Executive VP

                      Bruce N. Kuhlik

                      Executive VP/General Counsel

                      Richard R. DeLuca,Jr

                      Executive VP/President, Divisional

                      • Merck & Co Inc

                      • One Merck Drive

                      • Whitehouse Station, NJ 08889-0100

                      • USA.Map

                      • Phone: +1 908 423-1000

                      • Fax: +1 908 735-1253

                      • merck.com

                      Incorporated

                      1970

                      Employees

                      76,000

                      Send Feedback

                      We appreciate your input!

                      • I'm having trouble signing into my Microsoft account

                      • I’m having problems with the services stripe (Mail, Facebook, etc.)

                      • There is an issue with my weather information

                      • I see an error in the content

                      • Other

                      Please give an overall site rating: